FDA NDC Directory · JSON-LD · Markdown

Naproxen

NDC 31722-682 · HUMAN PRESCRIPTION DRUG · SUSPENSION

Labeler / ManufacturerCamber Pharmaceuticals, Inc.
Marketing categoryAbbreviated NDA (generic) · App ANDA215776
Dosage form / routeSUSPENSION · ORAL
Active ingredientsNAPROXEN (25 mg/mL)
Marketing started20220607
Package count1

External sources

Source: openFDA. Public-domain (CC0).